1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €1.47 (+488.00%). The median is €1.47 (+488.00%).
| Buy |
0 |
| Hold |
3 |
| Sell |
2 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | 2022 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | - |
| Net profit | -116.93M | 37.92% |
| EBITDA | -117.77M | 32.87% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €9.5M |
Number of shares | 41.85M |
52-week high/low | €0.72 - €0.12 |
| Dividends | No |
Beta | 2.29 |
P/E ratio | -0.08 |
PEG ratio | 0.00 |
P/B ratio | 0.17 |
P/S ratio | 0.00 |
Company profile
| Name | Applied Molecular Transport Inc |
| CEO | Shawn M. Cross |
| Employees | 13 |
Discover assets
Shareholders of Applied Molecular Transport Inc also invest in the following assets
